Orientbio, Inc. financial statements
Orientbio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | KRW 29.75B | EODHD |
| Net income | −KRW 4.57B | EODHD |
| Cash and equivalents | KRW 5.83B | EODHD |